Facebook
Twitter
LinkedIn
Forward
3rd Annual Bradley Z. Naifeh Amyloidosis Conference - Medical Professional Conference - March 22, 2025
Overview
In-Person and Virtual attendance options are available.
Houston Methodist J.C. Walter Conference Series
Presented by: Bradley Z. Naifeh Amyloidosis Clinical Research and Treatment Program at Houston Methodist J.C. Walter Jr. Transplant Center
Amyloidosis is an underrecognized condition because it has historically been misconceived to be a rare disease and presents in a myriad of clinical situations in a subtle manner. Recent advances in therapeutics have made it imperative that this condition is recognized and categorized appropriately in a timely manner so that individuals can get access to appropriate care. Due to a systemic nature of amyloid, various subspecialities are on the fore front of battling this disease. The goal of the Conference is to create a faculty panel from various disciplines to engage in the mission to promote awareness and educate attendees on Amyloidosis in a comprehensive manner.
FEES
| REGISTRATION TYPE | FEE |
|---|---|
| Physician (HM, MPAQ, ACO PCP) | Complimentary |
| Physician (Private physician located within the Greater Houston Area)* | $225 |
| Physician (Private physician located within the Greater Houston Area; NO CE) | Complimentary Click here to learn more and register as this registration type! |
| Physician (Private physician located outside the Greater Houston Area) | Complimentary |
| Allied Health Care Professionals / All Others | Complimentary |
| Resident / Fellow / Student (No CME) | Complimentary |
* In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.
Target Audience
Cardiologists, hematologists, neurologists, nephrologists, pulmonologists, hepatologists, nurse practitioners, nurses, social workers, transplant coordinators, and trainees in these subspecialities
Learning Objectives
Upon completion of this course, the participant should be able to:
- Identify and Diagnose Amyloidosis Early & Effectively
- Apply Best Practices to Treat Amyloidosis
- Utilize Appropriate Resources Available to Providers and Patients alike (non-profit institutions)
- Describe the full influence of Amyloidosis: how it affects multiple specialties and all parts of the body, and how it becomes a fatal disease
- List the multiple types of Amyloidosis
Program
| H O U S T O N M E T H O D I S T J . C . W A L T E R J R C O N F E R E N C E S E R I E S | ||
| 3rd Annual Bradley Z. Naifeh Amyloidosis Conference Medical Professionals Day Saturday, March 22, 2025 | Hybrid Symposium | ||
| TIME | PRESENTATION | SPEAKER(S) |
| 7:00 AM | Registration & Breakfast | |
| 8:00 AM | Executive Welcome Overview of Amyloidosis mission at Houston Methodist | R. Mark Ghobrial, MD, PhD, FACS, FRCS (Ed) |
| 8:05 AM | Introduction of the Bradley Z. Naifeh Amyloidosis Program | Arvind Bhimaraj, MD, MPH, FACC, FHFSA Barry Trachtenberg, MD, FACC Mahwash Kassi, MD |
| 8:10 AM | A message from the Naifeh Family | Valerie Naifeh |
| 8:20 AM | Amyloidosis: Common and uncommon types and Pathophysiology | Barry Trachtenberg, MD |
| 8:30 AM | Diagnostic work up of Cardiac Amyloidosis: Through suspicion to confirmation | Mouaz H. Al-Mallah, MD |
| PLENARY SESSION I: TTR Amyloidosis: Fundamental knowledge for everyone Moderators: Arvind Bhimaraj, MD; Barry Trachtenberg, MD Panelist: Luke Cunningham, MD; Anju Bhardwaj, MD | ||
| 8:40 AM | STATE OF THE ART LECTURE I Is Amyloid HFpEF? Implications for treatment and HFpEF trials | Mathew Maurer, MD |
| 9:10 AM | Red Flags beyond the heart: How to collaborate with non-cardiologists to Raise Awareness of Amyloid | Mazen Hanna, MD |
| 9:35 AM | AI and machine learning to help us Diagnose TTR Amyloidosis early | Sadeer Al-Kindi, MD |
| 9:45 AM | Genetic testing and cascade testing: How to screen families in h-ATTR | Mahwash Kassi, MD |
| 9:55 AM | Q&A and Panel Discussion | |
| 10:05 AM | Break | |
| PLENARY SESSION II: AL Amyloidosis: AL Amyloidosis: Overview, Relevance and Updates Moderators: Arvind Bhimaraj, MD; Barry Trachtenberg, MD Panelist: David W. Victor III, MD; Ajith Nair, MD | ||
| 10:20 AM | STATE OF THE ART LECTURE II The journey of Amyloidosis: From being rare to having dedicated conferences: A hematologists perspective | Morie Gertz, MD |
| 10:50 AM | Pathobiology and Initial evaluation of AL amyloidosis: Work up and distinguishing form other hematological entities | Siddharth Ganguly, MD |
| 11:00 AM | Kidney as a window to diagnosis and management after diagnosis: AL, TTR and Alec-2 | Abdul-Jabbar Khan, MD |
| 11:10 AM | Q&A and Panel Discussion | |
| PLENARY SESSION III: Patient Perspective and Support Groups: How to Support our Patients Moderators: Arvind Bhimaraj, MD; Barry Trachtenberg, MD Panelist: ASB, ARC, ASG, ICOS, Somebody To Talk To, Mackenzie's Mission | ||
| 11:20 AM | Life with Amyloidosis: A Personal Journey | Mackenzie's Mission Patient - Robert Chester |
| 11:30 AM | Pathways to Connect: Support Groups for Amyloidosis Patients Amyloidosis Speakers Bureau (ASB) Amyloidosis Research Consortium (ARC) Amyloidosis Support Groups (ASG) International Cardio-Oncology Society (IC-OS) Somebody To Talk To | ASB - Deb Boedicker ARC - Erin Poyant ASG - John Mathison IC-OS - Benjamin Lavine Somebody To Talk To - Dan Lier |
| 11:50 AM | Q&A and Panel Discussion | |
| 12:00 PM | Lunch | |
| 12:30 PM | PRODUCT THEATRE (Presented in Auditorium) *Not certified for CE credit* | |
| PLENARY SESSION IV: Treatment Options for Amyloidosis Moderators: Arvind Bhimaraj, MD; Barry Trachtenberg, MD Panelist: Sheetal Shroff, MD | ||
| 1:30 PM | Risk prognostication for amyloidosis: Initial and ongoing | Kelty Baker, MD |
| 1:40 PM | ATTR treatment options: Pharmacobiology of therapies and approved options | Mathew Maurer, MD |
| 1:55 PM | ATTR treatment on the horizon: Future looks promising | Mazen Hanna, MD |
| 2:10 PM | STATE OF THE ART LECTURE III Amyloid gets on the nerves: Clues and screening tools to detect hATTR polyneuropathy and ways of following treatment response | P. James Dyck, MD |
| 2:35 PM | Advances in AL-Amyloidosis treatment | Morie Gertz, MD |
| 2:55 PM | Q&A and Panel Discussion | |
| 3:05 PM | Concluding Remarks | A. Osama Gaber, MD, FACS |
| 3:15 PM | Adjourn | |
Venue
In-Person attendance will be held in the Houston Methodist Research Institute (6670 Bertner Avenue, Houston, Texas 77030).
Virtual information will be provided to registered learners.
Accreditation
Available Credit
- 5.25 AMA PRA Category 1 Credit™
Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Houston Methodist designates this Live activity for a maximum of 5.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 5.25 Attendance
- 5.25 Nursing Contact Hours
Houston Methodist is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Houston Methodist will award up to 5.25 nursing professional development contact hours for this activity.
- 6.00 Transplant CoordinatorsThe American Board for Transplant Certification (ABTC) has assigned the following Continuing Education Points for Transplant Certification (CEPTCs) to the following Houston Methodist Transplant Center educational program: 3rd Annual Bradley Z. Naifeh Amyloidosis Conference - Medical Professional Conference - March 22, 2025 | Wed, 10/16/2024 - 8:00am | 6.00 Category 1 CEPTCs
Exhibitors/Sponsors
Interested in exhibiting? Contact us for more information. The last day to register as an exhibitor/sponsor is Friday, March 7, 2025.
We gratefully acknowledge the following companies for participating as exhibitors for this activity:
Abbott
Alexion Pharmaceuticals
Alnylam
AstraZeneca
BridgeBio
CVRx
Orsini
Pantherx
Pfizer
United Therapeutics
We gratefully acknowledge the following companies for participating as a sponsor for this activity:
AstraZeneca - Lunch Sponsor
BridgeBio - Product Theater Sponsor
We gratefully acknowledge the following companies for providing an educational grant to partially support this activity:
AstraZeneca
Pfizer
Register/Take course
Price
REGISTRATION INSTRUCTIONS
- STEP 1 - Choose the activity format you would like to attend (LIVE or LIVESTREAM) by selecting the checkbox next to the activity and clicking the "Enroll" button.
- STEP 2 - Once enrolled, click the link of the activity format for which you enrolled (the Status should say "In progress") and then click the "Take Course" button to begin the activity.
FEES
| REGISTRATION TYPE | FEE |
|---|---|
| Physician (HM, MPAQ, ACO PCP) | Complimentary |
| Physician (Private physician located within the Greater Houston Area)* | $225 |
| Physician (Private physician located within the Greater Houston Area; NO CE) | Complimentary Click here to learn more and register as this registration type! |
| Physician (Private physician located outside the Greater Houston Area) | Complimentary |
| Allied Health Care Professionals / All Others | Complimentary |
| Resident / Fellow / Student (No CME) | Complimentary |
* In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.